BioWorld - Monday, April 20, 2026

BioWorld Science

June 14, 2021

View Archived Issues

Gunagratinib safe and active in patients with advanced solid tumors

Read More

Stuart initiates patient enrollment in phase II study of ST-100 for dry eye disease

Read More

PRV-111 nanoengineered cisplatin patch shows promising safety and efficacy in patient with OSCC

Read More

Shanghai Ennova Biopharmaceutical patents new TRK inhibitors

Read More

Sunshine Lake Pharma presents new antimigraine drugs

Read More

Shijiazhuang Yiling Pharmaceutical identifies HIPK2 inhibitors

Read More

Albiero Pharma synthesizes new ASBT and/or NTCP inhibitors

Read More

Preliminary first-in-human data presented for BDC-1001 in HER2-expressing solid tumors

Read More

Ossianix patents TfR1-targeting antibodies for neurodegeneration

Read More

U.K.'s MHRA clears initiation of phase II trial of COVID-DROPS

Read More

Phase Ia/b data for APTO-253 in patients with relapsed/refractory AML or high-risk MDS

Read More

Preliminary phase I results for NEXI-002 in R/R MM reported at EHA

Read More

Novavax reports COVID-19 vaccine data against SARS-CoV-2 Beta variant

Read More

Preliminary assessment of [68Ga]NOTA-GUL for the diagnosis of prostate cancer

Read More

ImmVira completes first dosing in phase II trials of oncolytic virus product MVR-T3011

Read More

Dosing begins in phase I study of novel cystic fibrosis therapy ETD-001

Read More

Rohto initiates phase I/II study of UDI-001 in pediatric patients with cerebral palsy

Read More

New target identified for acetaminophen liver injury

Read More

Inceptor Bio uses seed funding to advance next-generation cell therapy platforms for cancer

Read More

Lilly opens phase II trial of LY-3437943 in type 2 diabetes

Read More

First-in-human study of Carna's CDC7 inhibitor AS-0141 begins dosing

Read More

FDA lifts partial clinical hold on phase II studies of ALX-148 in HNSCC

Read More